ESMO 2025: Highlights and analysis
ESMO 2025: Highlights and analysis
Sacituzumab govitecan improves PFS in first-line metastatic TNBC patients unable to receive PD-(L)1 inhibitors
Zanzalintinib plus atezolizumab improves survival in refractory mCRC
Non-clear cell renal cell carcinoma: Management of papillary RCC
Supportive care intervention improves function and reduces fatigue in older lung cancer patients
WCLC 2025: Latest in EGFR positive NSCLC
Treatment management of favourable risk and very favourable risk patients
Transforming cancer care in India: The Access Cancer Care Initiative
The hidden biology of addiction and cancer
Burden and trends of breast cancer worldwide: Opportunities for prevention?
Managing cardiotoxicities for RCC treatment – Cardiologist’s perspective
Key insights from lung cancer research at ASCO 2025